Daily Cosmetic Research Analysis
Three impactful studies in cosmetic and aesthetic dermatology are highlighted today: a split-face randomized trial showing that adding supramolecular salicylic acid to 1927 nm thulium fiber laser enhances photoaging outcomes; a mechanistic study revealing that recombinant human fibronectin drives macrophage M2 polarization via NF-κB/TGF-β1 to boost fibroblast function; and a split-face clinical trial demonstrating a platinum-liposome mask accelerates post-photorejuvenation barrier recovery.
Summary
Three impactful studies in cosmetic and aesthetic dermatology are highlighted today: a split-face randomized trial showing that adding supramolecular salicylic acid to 1927 nm thulium fiber laser enhances photoaging outcomes; a mechanistic study revealing that recombinant human fibronectin drives macrophage M2 polarization via NF-κB/TGF-β1 to boost fibroblast function; and a split-face clinical trial demonstrating a platinum-liposome mask accelerates post-photorejuvenation barrier recovery.
Research Themes
- Combination regimens to enhance photoaging treatment
- Immunomodulatory mechanisms for skin regeneration
- Post-procedural barrier repair and soothing strategies
Selected Articles
1. Efficacy of combined 1927 nm thulium fiber laser and supramolecular salicylic acid in photoaging treatment.
In a split-face randomized clinical study of 36 adults with moderate-to-severe photoaging, adding supramolecular salicylic acid to a 1927 nm thulium fiber laser regimen produced greater improvements than laser alone. Objective indices (melanin, erythema, hydration, TEWL, dermal thickness, elasticity, and skin resilience) all favored the combination, with a significantly larger reduction in photoaging scores (10.51% vs 7.26%; P<0.001).
Impact: Demonstrates a practical, synergistic regimen that augments laser-based photoaging therapy with objective, multi-parameter improvements in a randomized split-face design.
Clinical Implications: Clinicians can consider adding SSA-based peels and topical SSA to 1927 nm TFL protocols to enhance pigmentary, barrier, and biomechanical outcomes in photoaged skin, while monitoring for peeling-related tolerability.
Key Findings
- Combination therapy reduced photoaging scores more than TFL alone (10.51% vs 7.26%; P<0.001).
- Objective parameters improved with combination: melanin index, erythema index, hydration, TEWL, dermal thickness (ultrasound), elasticity index, and skin resilience.
- Daily 2% SSA and fortnightly 30% SSA peels alongside four TFL sessions were well tolerated with an overall favorable safety profile.
Methodological Strengths
- Split-face randomized design with placebo control on the monotherapy side reduces inter-individual confounding.
- Use of multiple objective measures including ultrasound-based dermal thickness and biophysical skin parameters.
Limitations
- Single-center, small sample size with short-term follow-up through the treatment period.
- Potential for participant or evaluator unblinding due to visible peeling; durability of effects beyond the study window is unknown.
Future Directions: Conduct multicenter, longer-term randomized trials comparing various SSA concentrations/schedules with TFL across skin types, and include blinded outcome assessment and quality-of-life measures.
PURPOSE: 1927 nm fractional thulium fiber laser (TFL) has been shown to be effective in improving skin appearance by reducing pigmentation and loss of elasticity caused by photoaging. Supramolecular salicylic acid (SSA) has been utilized for chemical peeling with rejuvenation effect. This study aims to evaluate the effectiveness and safety of combined TFL and SSA treatment for photoaging. METHODS: Thirty-six patients with moderate-to-severe photoaging were enrolled and the two sides of the participants' face were randomly assigned to receive 30% SSA combined with TFL or TFL monotherapy. TFL was administered to both sides of the face on four occasions at four-week intervals, while the side receiving combined treatment additionally underwent eight chemical peels of 30% SSA fortnightly, supplemented by daily applications of 2% SSA. For the TFL-alone side, an equivalent dose of a placebo preparation was applied. The photographs, photoaging scores, melanin index (MI), erythema index (EI), skin hydration, trans-epidermal water loss (TEWL), dermal thickness, elasticity index, and skin rebound time were assessed. RESULTS: The combined TFL and SSA treatment was significantly more effective in reducing photoaging scores than TFL treatment alone. The average reduction in photoaging scores was 10.51% for the combined treatment group and 7.26% for the TFL-only group (P < 0.001). The combined therapy enhanced skin parameters including MI, EI, hydration, and TEWL, along with ultrasound-measured dermal thickness, elasticity index, and skin resilience post-treatment. CONCLUSION: The synergistic application of 1927 nm fractional thulium fiber laser and SSA for photoaging treatment has been demonstrated to be both effective and safe.
2. Recombinant Human Fibronectin Mediates Macrophage Polarization via NF-κB/TGF-β1 Pathway to Enhance Fibroblast Proliferation.
Recombinant human fibronectin shifted LPS-activated macrophages toward an anti-inflammatory M2 phenotype, increasing IL-10, Arg-1, and TGF-β1 while lowering TNF-α and IL-6. Conditioned media from these macrophages enhanced fibroblast proliferation, adhesion, and migration via TGF-β1/Smad2/3 signaling; NF-κB activation blunted these effects, and TGF-β1 inhibition abrogated them.
Impact: Provides mechanistic evidence linking an extracellular matrix protein to immunomodulation and fibroblast activation, offering a rational basis for designing pro-regenerative biomaterials and wound-healing strategies.
Clinical Implications: Although in vitro, the data suggest rhFN-based materials could modulate inflammation and accelerate tissue repair in aesthetic and reconstructive applications; in vivo validation is needed to assess efficacy and fibrosis risk.
Key Findings
- rhFN promoted macrophage M2 polarization, increasing IL-10, Arg-1, and TGF-β1 while reducing TNF-α and IL-6.
- Fibroblasts exposed to rhFN-treated macrophage-conditioned media exhibited increased Smad2/3 phosphorylation and enhanced proliferation, adhesion, and migration.
- NF-κB inhibition favored an anti-inflammatory macrophage profile; NF-κB activation partially reversed fibroblast benefits, and TGF-β1 blockade reduced fibroblast functional gains.
Methodological Strengths
- Mechanistic dissection using pathway modulation (NF-κB activation/inhibition and TGF-β1 blockade) supports causality.
- Multi-assay approach (flow cytometry, ELISA, Western blot, proliferation/adhesion/migration assays) across two interacting cell types via conditioned media.
Limitations
- Findings are limited to murine cell lines (RAW264.7, NIH 3T3) without in vivo validation.
- Dose-response, long-term phenotype stability, and effects on fibrosis or scarring were not assessed.
Future Directions: Test rhFN-based scaffolds in in vivo wound and scar models, quantify dose-response, and evaluate interactions with other ECM cues and immune cells across species.
OBJECTIVE: This research aims to explore the molecular mechanism where recombinant human fibronectin (rhFN) regulates macrophage polarization and then affects fibroblast proliferation via the nuclear factor kappa B (NF-κB)/transforming growth factor β1 (TGF-β1) signaling pathway. METHODS: Macrophages RAW 264.7 were activated with LPS and subsequently treated with rhFN, followed by flow cytometry to assess macrophag polarization. Cytokine levels of interleukin (IL)-10 tumor necrosis factor alpha (TNF-α), IL-6, and Arg-1, as well as TGF-β1, were measured using enzyme-linked immunosorbent assay (ELISA). Fibroblast NIH 3T3 was cultured with macrophage-conditioned media (CM), and CCK-8, cell adhesion, and wound healing assays were used to evaluate their proliferation, adhesion, and migration capacities. Western blot was conducted to detect the changes of proteins related to TGF-β1/Smad2/3 and NF-κB signaling. RESULTS: RhFN significantly promoted macrophage M2 polarization and increased TGF-β1 secretion while reducing pro-inflammatory cytokines TNF-α and IL-6, increasing IL-10 and Arg-1 levels. Fibroblasts cultured with rhFN-treated macrophage-CM showed increased Smad2/3 phosphorylation, causing improved proliferation, adhesion, and migration abilities. Inhibition of NF-κB signaling promoted an anti-inflammatory macrophage profile, while NF-κB activation partially reversed rhFN's effects on fibroblast function. Inhibition of TGF-β1 resulted in reduced fibroblast proliferation, adhesion, and migration abilities, confirming its pivotal role in rhFN-mediated effects. CONCLUSION: RhFN modulates macrophage polarization through NF-κB inhibition and promotes fibroblast proliferation, adhesion, and migration via TGF-β1/Smad2/3 signaling.
3. A Split-Face Randomized Study on the Efficacy of a Platinum-Liposome-Based Facial Mask Containing Soothing Ingredients for Post-Photorejuvenation Skin Recovery.
In vitro and clinical split-face data indicate that a platinum-liposome mask with soothing agents accelerates barrier repair after photorejuvenation. Hydration increased, TEWL decreased, and irritation signs improved from Day 1 through Day 14 without reported adverse effects.
Impact: Provides translational evidence linking biophysical barrier metrics to symptomatic relief in a randomized split-face setting, supporting a practical post-procedure care strategy.
Clinical Implications: Following photorejuvenation, clinicians may consider platinum-liposome-based masks with panthenol, dipotassium glycyrrhizate, and madecassoside to reduce TEWL and irritation and improve hydration during the first 2 weeks of recovery.
Key Findings
- Pt-liposomes increased stratum corneum thickness, cholesterol, and ceramide chain length in 3D skin/NHEK models (p<0.01).
- Combined Pt-liposomes plus soothing agents reduced IL-8 mRNA in LPS-stimulated THP-1 cells more than either alone (p<0.01).
- In a 30-subject split-face trial, hydration increased and TEWL decreased versus control from Day 1 to Day 14 (p<0.001); erythema, tightness, dryness, and scaliness improved without reported adverse events.
Methodological Strengths
- Randomized split-face clinical design with objective biophysical measurements over 14 days.
- Translational linkage from in vitro barrier/anti-inflammatory effects to clinical outcomes.
Limitations
- Short follow-up (14 days) and modest sample size may limit generalizability and long-term inference.
- Product-specific formulation; blinding of participants and evaluators may be challenging.
Future Directions: Evaluate durability and dose-response across device types and skin phototypes, include blinded assessments and patient-reported outcomes, and compare to standard post-procedure care.
BACKGROUND: Photorejuvenation is commonly employed to improve skin appearance but frequently leads to transient irritation and temporary impairment of skin barrier function. Incorporating platinum (Pt)-liposome technology along with soothing ingredients such as panthenol, dipotassium glycyrrhizate, madecassoside, and Portulaca oleracea extract is expected to offer enhanced reparative and anti-inflammatory effects, helping to alleviate post-procedural skin sensitivity and restore barrier integrity. AIMS: This study aimed to evaluate the efficacy of a Pt-liposome-based facial mask in promoting skin recovery and soothing irritation post-photorejuvenation. Furthermore, the study assessed potential synergistic benefits from combining Pt-liposomes with established soothing agents. PATIENTS/METHODS: We initially assessed the reparative effects of Pt-liposomes using a 3D epidermal skin model and normal human epidermal keratinocytes (NHEK), evaluating parameters such as stratum corneum thickness, cholesterol content, ceramide chain length, and inflammatory responses (IL-8 mRNA expression) following lipopolysaccharide (LPS) stimulation. A randomized, split-face clinical trial involving 30 subjects who underwent photorejuvenation treatment was then conducted. Each participant applied the Pt-liposome-infused facial mask to one side of the face and a control product on the other side. Skin hydration, transepidermal water loss (TEWL), and erythema, tightness, dryness, and scaliness were assessed using objective instrumentation and subjective evaluations at baseline and various intervals up to 14 days post-treatment. RESULTS: In vitro testing showed that Pt-liposomes significantly increased stratum corneum thickness, cholesterol levels, and ceramide chain length (p < 0.01). Pt-liposomes also reduced histamine-induced calcium influx in NHEK cells (p < 0.01). In LPS-stimulated THP-1 cells, combined treatment with Pt-liposomes and soothing agents resulted in a greater reduction in IL-8 mRNA expression compared to either component alone (p < 0.01). Clinical measurements indicated that the application of the Pt-liposome-based facial mask significantly increased skin hydration and reduced TEWL compared to control (p < 0.001) from Day 1 to Day 14. Subjective and dermatological evaluations showed statistically significant improvements in erythema, tightness, dryness, and scaliness on the treated side at all measured time points. No adverse reactions were reported. CONCLUSION: The Pt-liposome-infused facial mask can effectively promote skin barrier repair, alleviate irritation, and enhance hydration following photorejuvenation. Its synergistic combination with soothing ingredients provides rapid relief from irritation and sustained therapeutic benefits, supporting its potential as a safe and effective option for post-procedural skincare.